2019

1. CDK4/6 inhibitor as a novel therapeutic approach for advanced bladder cancer independently of RB1 status

   Clinical Cancer Research, Vol. 25, Núm. 1, pp. 390-402

2. Gene Expression Analyses in Non Muscle Invasive Bladder Cancer Reveals a Role for Alternative Splicing and Tp53 Status

   Scientific Reports, Vol. 9, Núm. 1

3. Inhibition of a G9a/DNMT network triggers immune-mediated bladder cancer regression

   Nature Medicine